Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Oct 14, 2021 9:25pm
129 Views
Post# 34007669

Todays House Positions + 110k OTC

Todays House Positions + 110k OTC
House Positions for C:ARCH from 20211014 to 20211014
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 47,900 112,455 2.348 3,500 8,090 2.311 44,400 -104,365
83 Mackie 38,100 91,928 2.413 11,300 27,806 2.461 26,800 -64,122
85 Scotia 19,860 48,115 2.423 50 113 2.26 19,810 -48,002
7 TD Sec 38,879 91,195 2.346 34,482 84,148 2.44 4,397 -7,047
14 ITG 4,013 9,534 2.376 254 616 2.425 3,759 -8,918
79 CIBC 21,100 51,172 2.425 19,540 47,555 2.434 1,560 -3,617
80 National Bank 1,579 3,691 2.338 263 613 2.331 1,316 -3,078
53 Morgan Stanley 293 730 2.491 0   293 -730
124 Questrade 466 1,085 2.328 500 1,225 2.45 -34 140
84 Ind Trading 0   66 155 2.348 -66 155
68 Leede 385 918 2.384 535 1,275 2.383 -150 357
13 Instinet 1,400 3,360 2.40 3,100 7,555 2.437 -1,700 4,195
2 RBC 11,141 27,048 2.428 14,201 34,280 2.414 -3,060 7,232
74 GMP 0   5,000 12,414 2.483 -5,000 12,414
143 Pershing 0   5,600 13,328 2.38 -5,600 13,328
9 BMO Nesbitt 0   30,500 74,710 2.45 -30,500 74,710
1 Anonymous 101,916 243,911 2.393 158,141 371,256 2.348 -56,225 127,345
TOTAL 287,032 685,142 2.387 287,032 685,139 2.387 0 -3

<< Previous
Bullboard Posts
Next >>